{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Squitti R"],"funding":["Alzheimer&apos;s Association","Alzheimer's Association"],"pagination":["960"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8301962"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(7)"],"pubmed_abstract":["Evidence indicates that patients with Alzheimer's dementia (AD) show signs of copper (Cu) dyshomeostasis. This study aimed at evaluating the potential of Cu dysregulation as an AD susceptibility factor. We performed a meta-analysis of 56 studies investigating Cu biomarkers in brain specimens (pooled total of 182 AD and 166 healthy controls, HC) and in serum/plasma (pooled total of 2929 AD and 3547 HC). We also completed a replication study of serum Cu biomarkers in 97 AD patients and 70 HC screened for rs732774 and rs1061472 <i>ATP7B</i>, the gene encoding for the Cu transporter ATPase7B. Our meta-analysis showed decreased Cu in AD brain specimens, increased Cu and nonbound ceruloplasmin (Non-Cp) Cu in serum/plasma samples, and unchanged ceruloplasmin. Serum/plasma Cu excess was associated"],"journal":["Biomolecules"],"pubmed_title":["Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating <i>ATP7B</i> Gene Variants."],"pmcid":["PMC8301962"],"funding_grant_id":["(PTC) PTC-19-602325"],"pubmed_authors":["Bonvicini C","Costa A","Ventriglia M","Binetti G","Benussi L","Simonelli I","Koch G","Rongioletti M","Ghidoni R","Sensi SL","Perini G","Squitti R","Borroni B","Albanese A"],"additional_accession":[]},"is_claimable":false,"name":"Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating <i>ATP7B</i> Gene Variants.","description":"Evidence indicates that patients with Alzheimer's dementia (AD) show signs of copper (Cu) dyshomeostasis. This study aimed at evaluating the potential of Cu dysregulation as an AD susceptibility factor. We performed a meta-analysis of 56 studies investigating Cu biomarkers in brain specimens (pooled total of 182 AD and 166 healthy controls, HC) and in serum/plasma (pooled total of 2929 AD and 3547 HC). We also completed a replication study of serum Cu biomarkers in 97 AD patients and 70 HC screened for rs732774 and rs1061472 <i>ATP7B</i>, the gene encoding for the Cu transporter ATPase7B. Our meta-analysis showed decreased Cu in AD brain specimens, increased Cu and nonbound ceruloplasmin (Non-Cp) Cu in serum/plasma samples, and unchanged ceruloplasmin. Serum/plasma Cu excess was associated","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Jun","modification":"2026-05-05T03:18:04.508Z","creation":"2022-02-10T23:33:56.227Z"},"accession":"S-EPMC8301962","cross_references":{"pubmed":["34209820"],"doi":["10.3390/biom11070960"]}}